CELZ
NASDAQ · Biotechnology
Creative Medical Technology
$1.94
-0.03 (-1.52%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,621.1% upside
Low Target
$22.85
Average Target
$33.39
High Target
$43.53
Current Price
$1.94
Current
$1.94
$1.94
Target
$33.39
$33.39
$22.85
$33.39 avg
$43.53
Scenario Analysis
Bear Case
$22.85
1,077.8%
Low target
Base Case
$33.39
+1,621.1%
Avg target
Bull Case
$43.53
+2,143.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.25
-69.0% from high
52-Week Low
$1.50
+29.0% from low
Target vs 52W High
$33.39
+434.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +18.4% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.8% |
| GILD | Strong Buy | 38 | 79% | $362.68 | +160.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -1.8% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.1% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.1% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -12.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -28.5% |